Smith SC, Allen J, Blair SN, Bonow RO, Brass LM, Fonarow GC, Grundy SM, Hiratzka L, Jones D, Krumholz HM , Mosca L, Pasternak RC, Pearson T, Pfeffer MA, Taubert KA
In MASLD, reduced SIRT1 activity leads to hyperacetylation and stabilization of PLIN2 and PLIN3, effectively locking lipid droplets and impairing lipophagic clearance, exacerbating triglyceride accumulation
Weight loss is not a linear experience
Yes, telehealth services like Doctronic.ai can evaluate your condition and prescribe Zepbound if appropriate, helping streamline the process
Active, not recruiting Obesity Type 2 Diabetes Drug: Tirzepatide Drug: Placebo A Study of Retatrutide (LY3437943) Compared to Tirzepatide (LY3298176) in Adults Who Have Obesity (TRIUMPH-5) The main purpose of this study is to evaluate the efficacy and safety of retatrutide compared to tirzepatide in adults who have obesity